| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010203 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 01/24/2002 | US20020010184 Inhibitors of prenyl-protein transferase |
| 01/24/2002 | US20020010182 Treatment of respiratory diseases such as asthma, bronchitis, rhinitis, cough, expectoration, ophthalmic diseases such as conjunctivitis, dermatitis |
| 01/24/2002 | US20020010179 Ultraviolet light screening agents; cosmetics |
| 01/24/2002 | US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma |
| 01/24/2002 | US20020010174 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 01/24/2002 | US20020010120 Composition and method for bleaching a substrate |
| 01/24/2002 | CA2416667A1 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | CA2415665A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | CA2415662A1 1-alkyl-3-[1-(substituted phenyl) benzotriazol-6-yl] uracils |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/23/2002 | EP1175128A2 Light emitting element and azole compound |
| 01/23/2002 | EP1173433A1 Cyanopyrroles as progesterone receptor agonists |
| 01/23/2002 | EP1173424A1 Pyrimidine compounds |
| 01/23/2002 | EP1173421A2 Indole derivatives as anti-inflammation agents |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 01/23/2002 | CN1332737A Thrombin inhibitors |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332166A Process for prep. of N-methyl-3-(1-methyl-4-piperidyl)-1H-indole-5-ethyl-sulfonamide |
| 01/23/2002 | CN1078210C Watersoluble azole antifungals |
| 01/23/2002 | CN1078208C Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 01/22/2002 | US6340758 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| 01/22/2002 | US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340683 Selective NPY (Y5) antagonists (triazines) |
| 01/22/2002 | US6340678 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them |
| 01/22/2002 | CA2043709C Antimigraine alkoxypyrimidine derivatives |
| 01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 01/17/2002 | WO2002004425A2 Viral polymerase inhibitors |
| 01/17/2002 | WO2002004424A1 Pyrazole derivatives |
| 01/17/2002 | WO2002003977A2 Combinations of statins, estrogenic agents and optionally estrogens |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001039759A3 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/17/2002 | US20020007075 Neurological disorders including physically damaged nerves and neurodegenerative diseases, and for treating alopecia and promoting hair growth; Alzheimer's, Parkinson's disease; amyotrophic lateral sclerosis |
| 01/17/2002 | US20020007071 Treating disorders which include neuropeptide Y excess; antagonists, antagonism |
| 01/17/2002 | US20020006952 Kinase inhibitors; anticancer agents |
| 01/17/2002 | US20020006948 Central nervous system disorders; antiinflammatory agents |
| 01/17/2002 | US20020006943 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/17/2002 | US20020006934 Phenyl-substituted imidazopyridines |
| 01/17/2002 | US20020006928 Phenyl-substituted indoles and indazoles |
| 01/17/2002 | CA2415492A1 Pyrazole derivatives |
| 01/17/2002 | CA2414060A1 Combinations of statins, estrogenic agents and optionally estrogens |
| 01/17/2002 | CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171428A1 Fab i inhibitors |
| 01/16/2002 | EP1171424A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP0880517B1 Quinazoline compounds |
| 01/16/2002 | EP0766678B1 Optical brightening agents |
| 01/16/2002 | EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 01/16/2002 | CN1331693A 1,2-annelated quinoline derivatives |
| 01/16/2002 | CN1331691A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331689A 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 01/16/2002 | CN1331682A Substituted 2-phenylbenzimidazoles, prodn. thereof and their use |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331677A Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/15/2002 | US6339101 Administering n-linked sulfonamide of an n-heterocyclic carboxylic acid derivative for therapy of nerve-related vision disorder, improving vision, therapy memory impairment or enhancing memory performance in an animal |
| 01/15/2002 | US6339099 Guanidine mimics as factor Xa inhibitors |
| 01/15/2002 | CA2028302C Benzimidazole derivatives, their production and use |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002531A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 01/10/2002 | WO2002002523A1 Process for preparing distamycin derivatives |
| 01/10/2002 | WO2002002488A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | US20020004600 Process for the preparation of substituted pyrimidines |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004032 Macrocyclic chelants for metallopharmaceuticals |
| 01/10/2002 | CA2415103A1 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2413243A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/09/2002 | EP1170290A2 Compounds having ultra-violet absorption properties |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1169320A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 01/09/2002 | EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
| 01/09/2002 | EP0918768B1 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 01/09/2002 | EP0607439B1 Nitrogenous heterocyclic compound |
| 01/09/2002 | CN1330654A 4,5-pyrrolo-oxindoles |
| 01/09/2002 | CN1330648A 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/09/2002 | CN1330647A 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 01/09/2002 | CN1330634A Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 01/09/2002 | CN1077572C 取代的吡咯 Substituted pyrrole |
| 01/09/2002 | CN1077571C Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 01/08/2002 | US6337344 Anticoagulants and enzyme inhibitors for cardiovascular disorders |
| 01/08/2002 | US6337342 Bis-aryl or heteroaryl indoles |
| 01/08/2002 | US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 01/08/2002 | US6337335 Enzyme inhibitors for autoimmune diseases, transplant rejection, grant versus host disease, hyperproliferative disorders and diseases in which cells receive pro-inflammatory signals. |